Marcia Ciccone

Dr. Ciccone is passionate about women’s health and about educating and empowering women to understand their bodies and the gynecologic and oncologic conditions that affect them. Her goal is to listen and to provide much needed comfort and hope in addition to cutting-edge and comprehensive cancer care. She has a special interest in the genetic basis of gynecological cancers and has obtained additional training and certification in cancer genetics which is at the forefront of both cancer prevention and targeted and individualized therapies.

Dr. Ciccone completed her fellowship and residency at USC and stayed here as staff because she is proud of the multidisciplinary care we are able to provide at our facilities. She enjoys being part of a specialty that allows her to see her patients through all aspects of their cancer care and to develop long-term relationships with them.

• Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapyAm J Obstet Gynecol. 2020 07; 223(1):103. e1-103. e13. . View in PubMed
• Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer Gynecol Oncol. 2023 06; 173:49-57. . View in PubMed
• Cancer Stage-Shifting with Sentinel Lymph Node Biopsy in Low-Grade Endometrial Cancer Ann Surg Oncol. 2023 06; 30(6):3191-3193. . View in PubMed
• Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy Eur J Surg Oncol. 2023 02; 49(2):461-467. . View in PubMed
• Our Space of Morrow Int J Gynecol Cancer. 2022 Nov 21. . View in PubMed
• Side-to-end reanastomosis after low-anterior resection (STELAR): Outcomes, feasibility, and description of procedure performed by a gynecologic oncology service J Surg Oncol. 2022 Sep; 126(3):563-570. . View in PubMed
• Predictors of subsequent pregnancy following medical treatment in obese women with complex atypical hyperplasia Arch Gynecol Obstet. 2022 07; 306(1):279-281. . View in PubMed
• Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer Gynecol Oncol. 2022 06; 165(3):428-436. . View in PubMed
• Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent US. trends. Eur J Surg Oncol. 2022 06; 48(6):1407-1413. . View in PubMed
• Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery Radiat Oncol. 2021 Aug 25; 16(1):162. . View in PubMed
• Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery Radiat Oncol. 2021 Jun 29; 16(1):123. . View in PubMed
• Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response? Gynecol Oncol Rep. 2021 Feb; 35:100700.. View in PubMed
• Recent changes in demographics and outcomes of cervical cancer in the United States Arch Gynecol Obstet. 2021 07; 304(1):1-3. . View in PubMed
• Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review Cancers (Basel). 2020 May 29; 12(6). . View in PubMed
• Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum Eur J Obstet Gynecol Reprod Biol. 2020 Mar; 246:194-196. . View in PubMed
• Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 12; 159(3):869-876. . View in PubMed
• Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia Int J Gynecol Cancer. 2020 09; 30(9):1331-1339. . View in PubMed
• Paraneoplastic Cushing’s syndrome and hypercalcemia arising from metastatic endometrioid endometrial adenocarcinoma: A case report Gynecol Oncol Rep. 2019 Aug; 29:58-60. . View in PubMed
• Emerging serine-threonine kinase inhibitors for treating ovarian cancer Expert Opin Emerg Drugs. 2019 12; 24(4):239-253. . View in PubMed
• Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia Arch Gynecol Obstet. 2019 03; 299(3):801-808. . View in PubMed
• Prolonged intubation after robotic-assisted hysterectomy for endometrial cancer: Case reports Gynecol Oncol Rep. 2018 Aug; 25:106-108. . View in PubMed
• Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series Gynecol Oncol Rep. 2018 Aug; 25:98-101. . View in PubMed
• Successful resuscitation after cardiac arrest secondary to carboplatin infusion: A case report Gynecol Oncol Rep. 2018 Feb; 23:7-9. . View in PubMed
• Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer Am J Clin Oncol. 2018 09; 41(9):851-860. . View in PubMed
• Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature Expert Opin Investig Drugs. 2016 Jul; 25(7):781-96. . View in PubMed
• Weight Change Pattern and Survival Outcome of Women with Endometrial Cancer Ann Surg Oncol. 2016 09; 23(9):2988-97. . View in PubMed
• Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome Obstet Gynecol. 2015 Feb; 125(2):424-433. . View in PubMed
• Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature Eur J Obstet Gynecol Reprod Biol. 2014 Aug; 179:216-23. . View in PubMed
• Toe metastasis: A rare pattern of cervical cancer spread Gynecol Oncol Case Rep. 2014 Apr; 8:7-9. . View in PubMed
• Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A Neuropharmacology. 2008 Oct; 55(5):763-70. . View in PubMed

• Matsuo, Koji
• Roman, Lynda
• Lenz, Heinz-Josef
• Wu-Williams, Anna
• Stanczyk, Frank
• Setiawan, Veronica